Sarah B. Simmons

ORCID: 0000-0001-5102-8060
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Systemic Sclerosis and Related Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • Immunotherapy and Immune Responses
  • Immune Response and Inflammation
  • Prion Diseases and Protein Misfolding
  • Vestibular and auditory disorders
  • Cell Adhesion Molecules Research
  • Cardiac Imaging and Diagnostics
  • Advanced MRI Techniques and Applications
  • Effects of Vibration on Health
  • Systemic Lupus Erythematosus Research
  • Amyotrophic Lateral Sclerosis Research
  • Radiation Dose and Imaging
  • Pregnancy and preeclampsia studies
  • Cerebral Palsy and Movement Disorders
  • T-cell and B-cell Immunology
  • Autoimmune and Inflammatory Disorders Research
  • Blood Coagulation and Thrombosis Mechanisms

Cleveland Clinic
2021-2023

University of Washington
2012-2023

Cleveland Clinic Lerner College of Medicine
2021

Abstract Multiple sclerosis (MS) is an autoimmune disease in which inflammatory lesions lead to tissue injury the brain and/or spinal cord. The specific sites of are strong determinants clinical outcome MS, but pathways that determine whether damage occurs or cord not understood. Previous studies mouse models MS demonstrated IFN-γ and IL-17 regulate lesion localization within brain; however, mechanisms by these cytokines mediate their effects have been identified. In present study, we show...

10.4049/jimmunol.1400807 article EN The Journal of Immunology 2014-06-10

Abstract Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput assays on widely accessible platforms in large, real‐world MS populations, is a critical step for sNfL to be utilized clinical practice. Methods Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) network healthcare institutions the United States Europe collecting standardized clinical/imaging data biospecimens during routine clinic visits. was 6974 201 healthy...

10.1002/acn3.51704 article EN cc-by Annals of Clinical and Translational Neurology 2022-11-25

<sec> <title>BACKGROUND</title> The benefits of physical activity are well-established in people with multiple sclerosis (MS), yet most MS insufficiently active. </sec> <title>OBJECTIVE</title> This article describes the study protocol for a randomized controlled trial designed to understand whether ExerciseRx digital health platform improves activity, symptoms, and functioning adults MS. <title>METHODS</title> Participants ambulatory (N = 106) who engage &lt;150 minutes per week moderate...

10.2196/preprints.72213 preprint EN cc-by 2025-02-06

Thrombin is a multifunctional serine proteinase that induces variety of responses from neural cells by cleavage proteinase-activated receptors (PARs) including PAR1 and PAR4. Thrombin/PAR signaling has been implicated in the neuroinflammatory response occurs brain following stroke other central nervous system pathologies. The involves astrocytes results induction proinflammatory chemokines interleukin-8 (IL-8 or CXCL8) interferon-γ-induced protein-10 (IP-10 CXCL10) these cells. Astroctyes...

10.1097/wnr.0b013e32835c1de4 article EN Neuroreport 2012-11-20

Aerobic exercise (AEx) has many potential benefits; however, it is unknown whether individuals with multiple sclerosis (MS) can attain the optimal intensity and duration to harness its effects. Forced-rate (FE) a novel paradigm in which voluntary pedaling rate during cycling supplemented achieve higher intensity. The aim of this pilot trial was investigate feasibility initial efficacy 12-week FE or (VE) intervention for MS.

10.7224/1537-2073.2023-042 article EN International Journal of MS Care 2023-12-04

Background: This Multiple Sclerosis (MS) is a Central Nervous System (CNS) disease characterized by demyelination or axonal loss encompassing several clinical subtypes—Relapsing-Remitting MS (RRMS), Secondary-Progressive (SPMS), and Primary-Progressive (PPMS). Strategies for treating progressive forms are limited, better understanding of underlying pathophysiology essential. Method: Somatosensory Evoked Potentials (SEP) were analyzed CNS conduction slowing caused myelin impairment defined...

10.35248/2376-0389.21.8.241 article EN Journal of Multiple Sclerosis 2021-01-01
Coming Soon ...